| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrine Research Laboratory, Department of Medicine, Montefiore Hospital and Medical Center, and Albert Einstein College of Medicine Bronx, N. Y.
Nondissociable complexes between 125I-labeled T3 (125I-T3) and plasma proteins were observed after incubation of 125I-T3 with plasma diluted 200-fold with phosphate buffer. The formation of these complexes was enhanced in the presence of Cu2+ and flavin mononucleotide and inhibited by reducing agents such as propylthiouracil, thiosulfate, dithiothreitol, and glutathione. The 125I-T3 protein complexes could be disrupted after digestion with pronase. T3 itself was identified as a constituent of the pronase digests by co-chromatography with authentic 131I-T3 to a constant isotopic ratio across the T3 area. Since treatment with 0.2% sodium dodecylsulfate or 8M urea did not disrupt the complexes, the T3-protein bond appears to have some of the characteristics of a covalent bond between hormone and protein.
1 Supported by USPHS Grant 9 R01-AM-15241-12, and U.S. Army Contract DA-49-193-MD-2967.
2 Career Scientist of the Health Research Council of New York City, Award 1-222.
Received February 7, 1972.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |